Cartesian Therapeutics, Inc. — Director's Dealing 2017

Apr 4, 2017

SEC Form 4/A — Form 4/A

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-07-29

Reporting Person: BARABE TIMOTHY C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-29	Stock Option (Right to Buy)	$11.00	A	12820	Acquired	2026-07-28	Common Stock (12820)	Direct

Footnotes

F1: The Form 4 filed on August 2, 2016 contained a Scrivener's error in the exercise price. This amendment has been filed solely to correct the exercise price of the July 29, 2016 grant from $10.99 to $11.00 per share.

F2: The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant.